Loading…
Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.
Political giving
$0
Political receipts
$0
Lobbying income
$58,280,195
Lobbying expense
—
Federal awards
$763,459
Relationships
642
| $930,000 |
| — |
| lobbied by | Inc. Pfizer | $780,000 | — |
| lobbied by | Sanofi Us Services Inc | $720,000 | — |
| lobbied by | Amgen | $640,000 | — |
| lobbied by | Partnership To Improve Patient Care | $630,000 | — |
| lobbied by | Susan G. Komen For The Cure | $620,000 | — |
| lobbied by | Glaxosmithkline | $600,000 | — |
| lobbied by | Coalition For The 21st Century | $525,000 | — |
| lobbied by | Inc. Gilead Sciences | $525,000 | — |
| lobbied by | Malaysia-Us Friendship Council | $500,000 | — |
| lobbied by | Malaysia-Us Friendship Council | $488,334 | — |
| lobbied by | Eli Lilly And Company | $480,000 | — |
| lobbied by | Amgen | $460,000 | — |
| lobbied by | State Of The Usa | $450,000 | — |
| lobbied by | Sanofi Us Services Inc | $450,000 | — |
| lobbied by | Eli Lilly And Company | $430,000 | — |
| lobbied by | Amgen | $420,000 | — |
| lobbied by | Coalition For The 21st Century | $420,000 | — |
| lobbied by | Amgen | $380,000 | — |
| lobbied by | Kleiner Perkins Caufield & Byers | $380,000 | — |
| lobbied by | Inc. Gilead Sciences | $376,000 | — |
| lobbied by | Eli Lilly And Company | $370,000 | — |
| lobbied by | Coalition For The 21st Century | $360,000 | — |
| lobbied by | Inc. Pfizer | $360,000 | — |
| lobbied by | Coalition For The 21st Century | $360,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America | $360,000 | — |
| lobbied by | Coalition For The 21st Century | $360,000 | — |
| lobbied by | Panflu Llc | $360,000 | — |
| lobbied by | Worby Groner Edelman & Napoli Bern | $350,000 | — |
| lobbied by | Coalition For The 21st Century | $350,000 | — |
| lobbied by | Coalition For The 21st Century | $340,000 | — |
| lobbied by | Eisai Corporation Of North America | $333,000 | — |
| lobbied by | Inc. Gilead Sciences | $330,000 | — |
| lobbied by | Inc. Gilead Sciences | $330,000 | — |
| lobbied by | Microsoft Corporation | $320,000 | — |
| lobbied by | Glaxosmithkline | $320,000 | — |
| lobbied by | Nanoink Inc | $305,000 | — |
| lobbied by | Becton Dickinson And Company | $301,000 | — |
| lobbied by | Sanofi Us Services Inc | $300,000 | — |
| lobbied by | Adamas Pharmaceuticals | $300,000 | — |
| lobbied by | Inc. Gilead Sciences | $300,000 | — |
| lobbied by | Coalition For The 21st Century | $280,000 | — |
| lobbied by | Coalition For The 21st Century | $280,000 | — |
| lobbied by | Coalition For The 21st Century | $280,000 | — |
| lobbied by | Coalition For The 21st Century | $280,000 | — |
| lobbied by | Amgen | $280,000 | — |
| lobbied by | Coalition For The 21st Century | $280,000 | — |